TVA Makes Second Investment in Glaucoma Therapy Company Camras Vision

TVA Makes Second Investment in Glaucoma Therapy Company Camras Vision

TVA Makes Second Investment in Glaucoma Therapy Company Camras Vision The Triangle Venture Alliance (TVA), an investment alliance among angel networks at Duke University, North Carolina State University, the University of North Carolina at Chapel Hill and North Carolina Central University, today announced an investment in Camras Vision, its second investment as an alliance. Camras has developed a glaucoma therapy that not only circumvents the complications of current glaucoma surgery methods, but can provide ophthalmologists with the first tool that can set specific pressures for patients. Glaucoma, a leading cause of irreversible blindness worldwide, is traditionally treated by lowering the […]

Read More…

Triangle Venture Alliance Makes Initial Investment Impact with Medical Device Company

Triangle Venture Alliance Makes Initial Investment Impact with Medical Device Company

Triangle Venture Alliance Makes Initial Investment Impact with Medical Device Company University-based Angel Networks Partner to Invest in 410 Medical, Help Company Transform Research into Products that Medical Providers Can Use to Serve Critically Ill Patients (Durham, N.C.— June 21, 2017) – Triangle Venture Alliance (TVA), a newly formed investment alliance among angel networks at North Carolina State University, Duke University, the University of North Carolina at Chapel Hill and NC Central University, today announced its first investment as an alliance – 410 Medical. 410 Medical is an early-stage medical device company that has developed and is now commercializing a […]

Read More…